Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 2/20 | 0.39 |
| ▸ | CA1 | P00915 | 10/20 | 0.38 |
| ▸ | CA2 | P00918 | 10/20 | 0.38 |
| ▸ | CA9 | Q16790 | 10/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | GAA | P10253 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | PTPRC | P08575 | 1/20 | 0.32 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.32 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.32 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.32 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL107837 | 0.86 | HDAC4 (0.36) | KDM4EGAAKMT2ASMN1; SMN2 | |
| SCHEMBL7508932 | 0.86 | GAA (0.47) | KDM4EGAAKMT2ASMN1; SMN2 | |
| SCHEMBL9008680 | 0.84 | KDM4E (0.33) | KDM4EGAAKMT2A | |
| Hydrochloric Acid SCHEMBL6558029 | 0.84 | GAA (0.49) | KDM4EGAAKMT2A | |
| SCHEMBL345721 | 0.83 | KDM4E (0.33) | KDM4EGAAKMT2A | |
| SCHEMBL154350 | 0.83 | KDM4E (0.33) | MAOBKDM4EGAAKMT2A | |
| SCHEMBL10578940 | 0.81 | KDM4E (0.32) | KDM4EGAAKMT2ASMN1; SMN2 | |
| SCHEMBL319902 | 0.81 | MAOB (0.43) | MAOBCA1CA2CA9KDM4E | |
| SCHEMBL8589236 | 0.79 | EPHX2 (0.32) | KDM4EGAA | |
| SCHEMBL16161453 | 0.79 | MAOB (0.43) | MAOBCA1CA2CA9KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9994726-B2 | Laminate, method for producing same, and gas barrier material | TOPPAN PRINTING CO., LTD. (JP) | 2018-06-12 | — | — | US | disclosed |
| US-20180131005-A1 | CARBON FIBER COMPOSITE, METHOD FOR PRODUCING SAME, CATALYST SUPPORT AND POLYMER ELECTROLYTE FUEL CELL | TOPPAN PRINTING CO., LTD. (JP) | 2018-05-10 | — | — | US | disclosed |
| US-9950846-B2 | Laminate, manufacturing method and shaped container | TOPPAN PRINTING CO., LTD. (JP) | 2018-04-24 | — | — | US | disclosed |
| US-20140356767-A1 | CARBON FIBER COMPOSITE, METHOD FOR PRODUCING SAME, CATALYST SUPPORT AND POLYMER ELECTROLYTE FUEL CELL | TOPPAN PRINTING CO., LTD. (JP) | 2014-12-04 | — | — | US | disclosed |
| US-20140017430-A1 | LAMINATE, MANUFACTURING METHOD AND SHAPED CONTAINER | TOPPAN PRINTING CO., LTD. (JP) | 2014-01-16 | — | — | US | disclosed |
| EP-2554589-A1 | FILM-FORMING COMPOSITION AND SHEET | Toppan Printing Co., Ltd. (JP) | 2013-02-06 | — | — | EP | disclosed |
| US-20130022827-A1 | Composition for Forming Film and Film Sheet | TOPPAN PRINTING CO., LTD. (JP) | 2013-01-24 | — | — | US | disclosed |
| US-7876596-B2 | Memory element and method for manufacturing same | WASEDA UNIVERSITY (JP) | 2011-01-25 | — | — | US | disclosed |
| US-20080259680-A1 | Memory Element and Method for Manufacturing Same | WASEDA UNIVERSITY (JP) | 2008-10-23 | — | — | US | disclosed |
| US-6710204-B2 | N-OXYL COMPOUND CONTAINED IN AN EASILY POLYMERIZABLE MATERIAL CAN BE SUFFICIENTLY DECREASED AND LOSS OF EASILY POLYMERIZABLE MATERIAL (ACRYLIC OR METHACRYLIC ACIDS OR THEIR ESTERS) IS LITTLE | MITSUBISHI RAYON CO., LTD. (JP) | 2004-03-23 | — | — | US | disclosed |
| US-20030078425-A1 | Decreasing method of N-oxyl compound | MITSUBISHI RAYON CO., LTD. (JP) | 2003-04-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030078425-A1 | Decreasing method of N-oxyl compound | NOC2L, LOXL2, VCL | MAOB 81/4885CA1 1210/4885CA2 2714/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.